Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy for chordoma.

D B Fuller1, J G Bloom

  • 1LDS Hospital Radiation Center, Salt Lake City, UT 84143.

International Journal of Radiation Oncology, Biology, Physics
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.

JAMA·1999
Same author

Osteopathic medical component missed in treating anterior hip pain.

The Journal of the American Osteopathic Association·1997
Same author

Superior sulcus tumors: combined modality.

The Annals of thoracic surgery·1994
Same author

Late effects following central nervous system radiation in a pediatric population.

Neuropediatrics·1992
Same author

Analysis of preoperative intracavitary cesium application versus postoperative external beam radiation in stage I endometrial carcinoma.

International journal of radiation oncology, biology, physics·1990
Same journal

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same journal

Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

International journal of radiation oncology, biology, physics·2026
Same journal

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

International journal of radiation oncology, biology, physics·2026
Same journal

Gastrointestinal Motility-Induced Interplay in Pancreas Proton Therapy: Motion Simulation and Dosimetric Impact.

International journal of radiation oncology, biology, physics·2026
Same journal

Intra-fractional Voxel-wise Anatomical Motion Tracking Guided by Multimodal Respiratory Surrogates in Radiotherapy: Framework Development and Multi-Center Validation.

International journal of radiation oncology, biology, physics·2026
Same journal

A Gaussian-based planning approach for robust dose-escalated stereotactic body proton therapy.

International journal of radiation oncology, biology, physics·2026
See all related articles

Radical radiotherapy for chordoma after surgery offered symptom relief for most patients, with higher doses improving local control. However, permanent cure was rare, highlighting local control as the primary challenge in managing this rare bone tumor.

Area of Science:

  • Oncology
  • Radiotherapy
  • Chordoma Research

Background:

  • Chordoma is a rare bone tumor often requiring multimodal treatment.
  • Gross residual chordoma after initial surgery presents a significant management challenge.
  • Radical radiotherapy has been used as a treatment modality for residual chordoma.

Purpose of the Study:

  • To evaluate the efficacy of radical radiotherapy in patients with gross residual chordoma.
  • To assess local control, survival rates, and symptom management following radiotherapy.
  • To determine the impact of radiotherapy dose on treatment outcomes.

Main Methods:

  • Retrospective analysis of 25 patients with gross residual chordoma treated with radical radiotherapy (1952-1981).
  • Evaluation of local progression, symptom status, survival rates, and distant metastases.

Related Experiment Videos

  • Correlation of radiotherapy dose (Gy, TDF) with local control duration.

    • Main Results:

    • Median freedom from local progression was 32 months; 96% experienced symptom stabilization or reduction.
    • Pain relief was achieved in all 19 patients with pain as a major symptom.
    • Actuarial 5- and 10-year survival rates were 44% and 17%, respectively; higher doses (>55 Gy) significantly improved local control.

    Conclusions:

    • Radical radiotherapy provides significant symptom relief and temporary local control for residual chordoma.
    • Higher radiotherapy doses are associated with improved duration of local control.
    • Achieving permanent cure remains difficult; high-dose, generous-volume radiotherapy is recommended.